Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Non-Small Cell Lung Cancer”

399 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 399 results

Testing effectiveness (Phase 2)Study completedNCT05577702
What this trial is testing

Efficacy, Safety, and Pharmacodynamics of Tislelizumab Monotherapy and Multiple Tislelizumab-based Immunotherapy Combinations in Participants With Resectable Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
BeiGene 121
Testing effectiveness (Phase 2)Study completedNCT00227539
What this trial is testing

Positron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University of Washington 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT05500092
What this trial is testing

An Open Label, Randomized Study of Neoadjuvant Nivolumab and Chemotherapy, With or Without Sub-ablative Stereotactic Body Radiation Therapy, for Resectable Stage IIA to IIIB Non-small Cell Lung Cancer

Who this might be right for
Resectable Stage IIA to IIIB Non-small Cell Lung Cancer
Montefiore Medical Center 17
Testing effectiveness (Phase 2)Looking for participantsNCT06492421
What this trial is testing

Neoadjuvant Intra-tumor Double Immunotherapy for Lung Cancer.

Who this might be right for
Lung CancerSurgeryNon-small Cell Lung Cancer
Second Affiliated Hospital of Guangzhou Medical University 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT06055465
What this trial is testing

Neoadjuvant Sacituzumab Govitecan Plus Pembrolizumab in Resectable Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Chinese University of Hong Kong 37
Testing effectiveness (Phase 2)Study completedNCT02927301
What this trial is testing

Atezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Lung Cancer Mutation Consortium (LCMC3)

Who this might be right for
Non-Small Cell Lung Cancer
Genentech, Inc. 181
Testing effectiveness (Phase 2)Study completedNCT03088930
What this trial is testing

Evaluating Crizotinib in the Neoadjuvant Setting in Patients With Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer, Nonsmall Cell
University of Colorado, Denver 3
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07241819
What this trial is testing

Ivonescimab Monotherapy or in Combination With Chemotherapy as Neoadjuvant/Adjuvant Therapy for Resectable Non-small Cell Lung Cancer

Who this might be right for
II-IIIB (T3N2) Resectable Non-small Cell Lung CancerPerioperative
Peking University Cancer Hospital & Institute 66
Testing effectiveness (Phase 2)UnknownNCT04181372
What this trial is testing

Neoadjuvant Chemotherapy Plus Anlotinib in Stage III(N2) Non-small-cell Lung Cancer

Who this might be right for
Stage III Non-small-cell Lung Cancer
The First Affiliated Hospital of Guangzhou Medical University 50
Testing effectiveness (Phase 2)UnknownNCT06391008
What this trial is testing

Immunosensitized Radiotherapy Combined With Evoximab (AK112) and Chemotherapy Neoadjuvant Therapy for Stage II-III Non-small Cell Lung Cancer

Who this might be right for
Stereotactic Radiotherapy; Evoximab (AK112); New Adjuvant Therapy for Non-small Cell Lung Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 44
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07720167
What this trial is testing

Cemiplimab for Clinical Stage I, 2-3.9cm, Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Medical University of South Carolina 38
Not applicableNot Yet RecruitingNCT07502963
What this trial is testing

Effectiveness of a Multimodal Outpatient Supervised Physical Activity Program to Improve Tolerance and Efficacy of Chemotherapy in Adults With Breast, Lung and Colon Cancer

Who this might be right for
Breast CancerLung Cancer (Non-Small Cell)Colorectal Cancer+3 more
University of Vic - Central University of Catalonia 70
Not applicableNot Yet RecruitingNCT07538193
What this trial is testing

Iparomlimab and Tuvonralimab Plus Chemotherapy Before Surgery for Stage III Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung (NSCLC)Neoplasm StagingLymphatic Metastasis
Tang-Du Hospital 28
Testing effectiveness (Phase 2)Looking for participantsNCT06755684
What this trial is testing

Neoadjuvant Befotertinib Combined Bevacizumab or Platinum-based Double Chemotherapy for Resectable Locally-advanced EGFR Mutation-positive Non-Small Cell Lung Cancer

Who this might be right for
EGFRNon-Small Cell Lung CancerLocally Advanced Non-Small Cell Lung Cancer+5 more
Peng Zhang 60
Testing effectiveness (Phase 2)UnknownNCT01054482
What this trial is testing

Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in Locally Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
The First Affiliated Hospital of Guangzhou Medical University 120
Not applicableWithdrawnNCT00859742
What this trial is testing

Endobronchial Ultrasound Guided Transbronchial Needle Aspiration (EBUS-TBNA) for Mediastinal Re-staging of Non-small Cell Lung Cancer(NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
National Cancer Center, Korea
Testing effectiveness (Phase 2)UnknownNCT05611879
What this trial is testing

Neoadjuvant of Tislelizumab Combined With Chemotherapy Followed by Surgery in Unresectable Stage Ⅲ NSCLC

Who this might be right for
NSCLC, Stage III
Beijing Tsinghua Chang Gung Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07573696
What this trial is testing

Multidisciplinary Treatment of Stage III ALK+ NSCLC With Neoadjuvant Alectinib and Chemotherapy

Who this might be right for
Nonsmall Cell Lung Cancer Stage III
Wen-zhao ZHONG 50
Testing effectiveness (Phase 2)Ended earlyNCT02276560
What this trial is testing

Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC

Who this might be right for
Stage IIIA Non-Small Cell Lung Cancer
UNC Lineberger Comprehensive Cancer Center 1
Testing effectiveness (Phase 2)Ended earlyNCT03574818
What this trial is testing

Necitumumab in the Neoadjuvant Setting With Gemcitabine in Surgically Resectable - 14X-US-I001

Who this might be right for
Squamous Cell Lung Cancer
Montefiore Medical Center 1
Next Page